Mean age (years) | 47.24 ± 17.09 | ||
Sex-ratio (M/F) | 0.82 | ||
Average annual income (euro) | 1163.44 [0 - 5594.6] | ||
| Frequency | Percentage | |
Glaucoma stage (MD* in dB**) |
|
| |
| Stage 1-Early (MD > −6 dB) | 71 | 47.3% |
| Stage 2-Moderate (−12 < MD < −6) | 42 | 28% |
| Stage 3-Advanced (−20 < MD < −12) | 36 | 24% |
| Stage 4-Severe (MD < −20) | 1 | 0.7% |
Eye drops Treatment |
|
| |
Beta blockers | 86 | 48% | |
Prostaglandins | 60 | 33.6% | |
Carbonic anhydrase Inhibitors | 26 | 14.6% | |
Cholinergic Agents | 5 | 2.8% | |
Alpha-adrenergic agonists | 2 | 1.1% | |
Laser |
|
| |
SLT Laser | 1 | 0.6% | |
Surgery |
|
| |
| Trabeculectomy | 2 | 1.3% |